Suppr超能文献

普萘洛尔即刻反应:一种极其罕见但重要的情况。病例报告。

Immediate Reaction to Propranolol: An Extremely Rare but Important Condition. A Case Report.

机构信息

Departamento de Medicina y Especialidades Médicas, Servicio de Enfermedades del Sistema Inmune-Alergia, Hospital Universitario Príncipe de Asturias, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.

出版信息

Curr Drug Saf. 2024;19(2):303-305. doi: 10.2174/1574886318666230417103423.

Abstract

INTRODUCTION

Beta-blockers involve a group of drugs widely used nowadays. Propranolol was the first beta-blocker available in the market. It is the most prescribed first-generation betablocker and is commonly used. Beta-blocker allergy is extremely unusual. Only an isolated case of an urticaria reaction to propranolol has been published in 1975.

CASE PRESENTATION

We present a 44-year-old man. In 2016, he was treated with a daily dose of 5 mg of propranolol prescribed for a diagnosis of essential tremor. On the third day of medical treatment, he experienced an episode of generalized urticaria directly related to the administration of propranolol. He continued with his habitual treatment and he had no other urticaria episodes. A drug provocation test was carried out with gradually increasing doses of the culprit drug. Thirty minutes after a total cumulative dose of 5 mg, the patient had several hives on the chest, abdominal region and arms. Two weeks later, a new drug provocation test was performed to bisoprolol as an alternative beta-blocker, with good tolerance.

CONCLUSION

We describe a new case of urticaria secondary to propranolol, presenting as an immediate hypersensitivity reaction. Bisoprolol has been succesfully proved to be a safe option. Bisoprolol is a second-generation beta-blocker, it is available and commercialized worldwide, which makes it a good alternative.

摘要

简介

β受体阻滞剂是目前广泛应用的一类药物。普萘洛尔是最早上市的β受体阻滞剂。它是最常被开处方的第一代β受体阻滞剂,应用广泛。β受体阻滞剂过敏极为罕见。1975 年仅发表过一例孤立的普萘洛尔荨麻疹反应病例。

病例介绍

我们介绍一位 44 岁男性,2016 年因特发性震颤,每日接受 5mg 普萘洛尔治疗。治疗第 3 天,他出现全身性荨麻疹,与普萘洛尔给药直接相关。他继续接受常规治疗,未再出现荨麻疹。随后进行药物激发试验,逐渐增加药物剂量。总累积剂量达 5mg 后 30 分钟,患者胸部、腹部和手臂出现多处风团。2 周后,进行了新的药物激发试验,改用比索洛尔作为替代的β受体阻滞剂,耐受良好。

结论

我们描述了一例新的普萘洛尔引起的荨麻疹病例,表现为速发型超敏反应。比索洛尔已被证明是一种安全的选择。比索洛尔是第二代β受体阻滞剂,在全球范围内均可获得和商业化,是一种很好的替代药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验